Lobbying client

TITAN PHARMACEUTICALS, INC.

Pharmaceutical company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
25
Filed by
2
Reported in-house
—
Reported by firms
$160,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2018 to 2021

Filings

25 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2021
HANCE SCARBOROUGH — reported
4th Quarter - Termination
4th Quarter 2020
THE LIVINGSTON GROUP, LLC $10,000 reported
4th Quarter - Report (No Activity)
4th Quarter 2020
HANCE SCARBOROUGH — reported
4th Quarter - Reportreplaced
4th Quarter 2020
THE LIVINGSTON GROUP, LLC $20,000 reported
3rd Quarter - Report
3rd Quarter 2020
THE LIVINGSTON GROUP, LLC $20,000 reported
3rd Quarter - Report (No Activity)
3rd Quarter 2020
HANCE SCARBOROUGH — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2020
HANCE SCARBOROUGH — reported
2nd Quarter - Report
2nd Quarter 2020
THE LIVINGSTON GROUP, LLC $20,000 reported
1st Quarter - Report (No Activity)
1st Quarter 2020
HANCE SCARBOROUGH — reported
1st Quarter - Report
1st Quarter 2020
THE LIVINGSTON GROUP, LLC $20,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE LIVINGSTON GROUP, LLC 9 $160,000
HANCE SCARBOROUGH 13 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 2456 115th 20

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.